Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GOVX is expected to report earnings to fall 60.69% to -102 cents per share on November 05
Q3'26
Est.
$-1.03
Q1'26
Missed
by $2.08
Q4'25
Missed
by $2.27
Q3'25
Missed
by $0.02
Q2'25
Missed
by $0.05
The last earnings report on April 30 showed earnings per share of -261 cents, missing the estimate of -54 cents. With 357.99K shares outstanding, the current market capitalization sits at 3.36M.